98 related articles for article (PubMed ID: 16187022)
1. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.
Haque A; Das A; Hajiaghamohseni LM; Younger A; Banik NL; Ray SK
Cancer Immunol Immunother; 2007 May; 56(5):615-25. PubMed ID: 16947022
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in astrocytomas: deposition of C4d and patient outcome.
Mäkelä K; Helén P; Haapasalo H; Paavonen T
BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
[TBL] [Abstract][Full Text] [Related]
3. Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.
Bachmann A; Hanke B; Zawatzky R; Soto U; van Riggelen J; zur Hausen H; Rösl F
J Virol; 2002 Jan; 76(1):280-91. PubMed ID: 11739693
[TBL] [Abstract][Full Text] [Related]
4. Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook.
Chen T; Li S; Deng D; Zhang W; Zhang J; Shen Z
J Zhejiang Univ Sci B; 2024 Jun; 25(6):451-470. PubMed ID: 38910492
[TBL] [Abstract][Full Text] [Related]
5. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
[TBL] [Abstract][Full Text] [Related]
6. Influence of IFN-gamma and its receptors in human breast cancer.
García-Tuñón I; Ricote M; Ruiz A A; Fraile B; Paniagua R; Royuela M
BMC Cancer; 2007 Aug; 7():158. PubMed ID: 17697357
[TBL] [Abstract][Full Text] [Related]
7. Single-cell Western blotting after whole-cell imaging to assess cancer chemotherapeutic response.
Kang CC; Lin JM; Xu Z; Kumar S; Herr AE
Anal Chem; 2014 Oct; 86(20):10429-36. PubMed ID: 25226230
[TBL] [Abstract][Full Text] [Related]
8. Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.
Liang J; Piao Y; Henry V; Tiao N; de Groot JF
Oncotarget; 2015 Oct; 6(31):31479-92. PubMed ID: 26362401
[TBL] [Abstract][Full Text] [Related]
9. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment.
Neufeld L; Yeini E; Reisman N; Shtilerman Y; Ben-Shushan D; Pozzi S; Madi A; Tiram G; Eldar-Boock A; Ferber S; Grossman R; Ram Z; Satchi-Fainaro R
Sci Adv; 2021 Aug; 7(34):. PubMed ID: 34407932
[TBL] [Abstract][Full Text] [Related]
10. Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma.
Asano K; Fumoto T; Matsuzaka M; Hasegawa S; Suzuki N; Akasaka K; Katayama K; Kamataki A; Kurose A; Ohkuma H
BMC Cancer; 2021 Jul; 21(1):867. PubMed ID: 34320929
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells.
Ochiai Y; Sumi K; Sano E; Yoshimura S; Yamamuro S; Ogino A; Ueda T; Suzuki Y; Nakayama T; Hara H; Katayama Y; Yoshino A
Oncol Lett; 2020 Nov; 20(5):178. PubMed ID: 32934745
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 1 inactivation in human cancer.
Alsamman K; El-Masry OS
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29599126
[TBL] [Abstract][Full Text] [Related]
13. Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells.
Yamamuro S; Sano E; Okamoto Y; Ochiai Y; Ohta T; Ogino A; Natsume A; Wakabayashi T; Ueda T; Hara H; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Nov; 47(5):1647-54. PubMed ID: 26397698
[TBL] [Abstract][Full Text] [Related]
14. Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.
Zemp FJ; McKenzie BA; Lun X; Maxwell L; Reilly KM; McFadden G; Yong VW; Forsyth PA
PLoS One; 2013; 8(6):e65801. PubMed ID: 23762429
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
[TBL] [Abstract][Full Text] [Related]
16. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.
Kim EJ; Lee JM; Namkoong SE; Um SJ; Park JS
J Cell Biochem; 2002; 85(2):369-80. PubMed ID: 11948692
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic exploitation of apoptosis and autophagy for glioblastoma.
Kögel D; Fulda S; Mittelbronn M
Anticancer Agents Med Chem; 2010 Jul; 10(6):438-49. PubMed ID: 20879985
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
